Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 296

1.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

3.

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.

Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J.

Am J Clin Nutr. 2006 Jul;84(1):5-17. Review.

4.

Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.

Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B.

Herz. 2004 Nov;29(7):673-85. Review. Erratum in: Herz. 2004 Dec;29(8):805.

PMID:
15580322
5.

Effect of fish oil on arrhythmias and mortality: systematic review.

León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT.

BMJ. 2008 Dec 23;337:a2931. doi: 10.1136/bmj.a2931. Review.

6.

n-3 fatty acids and cardiovascular disease.

Breslow JL.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1477S-1482S. Review.

7.

Cardiovascular disease prevention and treatment.

von Schacky C.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):193-8. doi: 10.1016/j.plefa.2009.05.009. Epub 2009 Jun 10. Review.

PMID:
19520557
8.

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group.

Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262. Review.

PMID:
22493407
9.

Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.

Rupp H.

Adv Ther. 2009 Jul;26(7):675-90. doi: 10.1007/s12325-009-0045-2. Epub 2009 Jul 27. Review.

PMID:
19629408
10.
11.

Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.

Holub BJ.

Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):199-204. doi: 10.1016/j.plefa.2009.05.016. Epub 2009 Jul 9. Review.

PMID:
19545988
12.

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

Lavie CJ, Milani RV, Mehra MR, Ventura HO.

J Am Coll Cardiol. 2009 Aug 11;54(7):585-94. doi: 10.1016/j.jacc.2009.02.084. Review.

13.

Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.

Pauwels EK, Kostkiewicz M.

Drug News Perspect. 2008 Dec;21(10):552-61. doi: 10.1358/dnp.2008.21.10.1314058. Review.

PMID:
19221636
14.

[Omega-3 fatty acids in cardiology. Latest developments].

von Schacky C.

MMW Fortschr Med. 2007 Sep 13;149 Suppl 3:97-101. Review. German.

PMID:
17955786
15.

Dietary omega-3 fatty acid intake and cardiovascular risk.

Psota TL, Gebauer SK, Kris-Etherton P.

Am J Cardiol. 2006 Aug 21;98(4A):3i-18i. Epub 2006 May 30. Review.

PMID:
16919512
16.

Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".

Rupp H, Rupp TP, Wagner D, Alter P, Maisch B.

Herz. 2006 Dec;31 Suppl 3:30-49. Review.

PMID:
17575804
17.

Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.

Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):808-18. doi: 10.1161/CIRCOUTCOMES.112.966168. Epub 2012 Oct 30. Review.

18.

Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling.

Brownawell AM, Harris WS, Hibbeln JR, Klurfeld DM, Newton I, Yates A.

Nutr Rev. 2009 Jul;67(7):391-7. doi: 10.1111/j.1753-4887.2009.00212.x. Review.

PMID:
19566599
19.

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.

Berger JS, Brown DL, Becker RC.

Am J Med. 2008 Jan;121(1):43-9. doi: 10.1016/j.amjmed.2007.10.002. Review.

PMID:
18187072
20.

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS.

JAMA. 2012 Sep 12;308(10):1024-33. doi: 10.1001/2012.jama.11374. Review.

PMID:
22968891
Items per page

Supplemental Content

Write to the Help Desk